Mostrar el registro sencillo del ítem
dc.contributor.author
Rodriguez Cairoli, Federico
dc.contributor.author
Appiani, Francisco
dc.contributor.author
Sambade, Juan Manuel
dc.contributor.author
Comandé, Daniel
dc.contributor.author
Camacho Arteaga, Lina
dc.contributor.author
Ciapponi, Agustín
dc.date.available
2022-10-31T10:50:59Z
dc.date.issued
2021-06
dc.identifier.citation
Rodriguez Cairoli, Federico; Appiani, Francisco; Sambade, Juan Manuel; Comandé, Daniel; Camacho Arteaga, Lina; et al.; Efficacy and safety of opioid therapy guided by pharmacogenetics: A systematic review; Future Medicine; Pharmacogenomics; 22; 9; 6-2021; 573-586
dc.identifier.issn
1462-2416
dc.identifier.uri
http://hdl.handle.net/11336/175522
dc.description.abstract
Aim: To perform a systematic review to determine the efficacy/safety of PGx-guided opioid therapy for chronic/postoperative pain. Materials & methods: We searched PubMed and other specialized databases. Articles were considered if they compared the efficacy/safety of PGx-guided opioid therapy versus usual care. The risk of bias assessment was performed using Cochrane tools. Results: A total of 3794 records were retrieved. Only five were included for data extraction. A lower requirement of analgesics during postoperative in the PGx-guided intervention arm was reported in two studies. Also, two studies reported significant pain improvement in favor of the PGx-guided therapy when analyzing the subgroup of patients with a high-risk CYP2D6 phenotype. Conclusion: Despite the findings described, information on the efficacy/safety of this intervention is scarce.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Future Medicine
dc.rights
info:eu-repo/semantics/restrictedAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
opioid therapy
dc.subject
systematic review
dc.subject.classification
Otras Ciencias de la Salud
dc.subject.classification
Ciencias de la Salud
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Efficacy and safety of opioid therapy guided by pharmacogenetics: A systematic review
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2022-09-29T13:46:52Z
dc.journal.volume
22
dc.journal.number
9
dc.journal.pagination
573-586
dc.journal.pais
Reino Unido
dc.journal.ciudad
Londres
dc.description.fil
Fil: Rodriguez Cairoli, Federico. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina. Instituto de Efectividad Clínica y Sanitaria; Argentina
dc.description.fil
Fil: Appiani, Francisco. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
dc.description.fil
Fil: Sambade, Juan Manuel. Provincia de Buenos Aires. Municipalidad de Vicente López. Hospital Municipal Doctor Bernardo Houssay; Argentina
dc.description.fil
Fil: Comandé, Daniel. Instituto de Efectividad Clínica y Sanitaria; Argentina
dc.description.fil
Fil: Camacho Arteaga, Lina. Universidad Autónoma de Barcelona. Hospital Vall D' Hebron; España
dc.description.fil
Fil: Ciapponi, Agustín. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina
dc.journal.title
Pharmacogenomics
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.2217/pgs-2021-0021
Archivos asociados